With the advent of assisted reproductive technology and an improved understanding of cryobiology, strategies have been developed which allow the long-term storage of gametes and embryos. Furthermore, in the light of the growing numbers of young adults and children who have been sterilised by successful cancer treatment, the need to protect their fertile potential has become more urgent. While semen cryopreservation is available for men, the methods for preserving oocytes are unreliable and neither method is suitable for prepubertal children. Research attention is, therefore, focusing on the low temperature banking of immature germ cells with the aim to restore natural fertility if possible or, alternatively, to use culture technology to produce ripe gametes for assisted conception. While there is no universal method for fertility conservation, gonadal tissue banking, in theory, is a practical alternative to gamete storage which can be utilised by both adults and children.
malignancies and a marked increase in the chances of long-term survival 4 .
Estimates now suggest that by the beginning of the new millennium at least 1:1000 adults will be survivors of childhood cancers 5 . However, the price that is paid for aggressive chemotherapy and abdominal irradiation is becoming increasingly unacceptable. The documented late effects of these treatments, including reduced pregnancy rates and a high risk of gonadal failure 6 , are of particular concern because of the young median age of these patients. Furthermore, in young women, even if ovarian failure does not occur immediately, there is a substantial risk of premature menopause, particularly in those aged over 30 years 7 . Frozen banking of gonadal tissues and cells before the start of cancer treatment, therefore, represents an attractive strategy for conserving the fertility of children and young adults of both sexes.
Frozen semen banking has been available for many years to safeguard male fertility and is routinely offered to men before they undergo sterilising chemotherapy. Despite the production of often poor quality semen in this circumstance 8 , the use of intracytoplasmic sperm injection (ICSI) has substantially improved the potential to use these stored cells. Furthermore, some clinical and experimental studies have indicated that the sterilising effects of cancer treatments can be reduced by hypogonadotrophism 9, 10 , and treatment with GnRH agonists has been advocated to protect the gonads in both sexes. However, overall, the evidence for clinical benefit is inconclusive and some experimental studies have revealed no protective effect of hypogonadotrophism on radio sensitivity 11 . The options for preserving female fertility are unreliable and complex. In theory, the only proven method for the conservation of the fertility of young women is assisted reproductive technology which enables collection and storage of mature metaphase II oocytes and, more practically, embryos. The storage of unfertilised human oocytes would avoid many of the ethical issues related to human embryo storage and facilitate egg donation programmes. Spare oocytes would be collected and stored during IVF cycles so that patients could use them at a later time or donate them to another person or for research. The opportunity to bank oocytes at low temperatures would be welcomed by young women undergoing sterilising chemotherapy as well by as others who wish to safeguard fertility from an early menopause or from the deleterious effects of ageing 12 . There is little doubt that the freeze storage of human oocytes would be a valuable technique in clinically-assisted reproduction, in animal husbandry and in the conservation of endangered species.
Numerous attempts have been made to freeze-thaw human oocytes, but success rates have been disappointing and can be attributed, in part, to the biological properties of this cell type. Ovulated oocytes are blocked at the metaphase of the second meiotic division with 23 bivalent chromosomes bound to the microtubules of the meiotic spindle. In this state, the oocytes are extremely sensitive to both temperature and toxic shocks. Cryoprotectant exposure and/or ice crystal formation during the freeze-thaw process can lead to depolarisation of the spindle microtubules, disruption of chromatid separation at the moment of fertilisation, and the potential induction of aneuploidy after the extrusion of the second polar body. Furthermore, zona hardening can occur as a result of the premature release of cortical granules from the ooplasm 13 or lesions can be induced in the zona and plasma membrane by large ice crystals 14 . Finally, parthenogenetic activation can be induced by physical conditions such as freezing 15 . It is not surprising, therefore, that the first attempts to cryopreserve metaphase II oocytes resulted in poor cryosurvival with few live births 16 . However, since the introduction of different cryoprotective agents and ICSI, as a means of bypassing the zona pellucida, fertilisation and pregnancy rates of cryopreserved oocytes have improved 17, 18 . However, the protocols that have been used in oocyte cryopreservation are still not optimal for this cell and authors have argued both for 19, 20 and against 17, 21 the maintenance of the cumulus oophorus to optimise oocyte survival rate. Despite this, cryopreservation of mature human oocytes has resulted in the production of healthy offspring with normal karyotypes suggesting that the process of freezing may select the most resistant oocytes which are best able to survive different stresses.
An alternative strategy to the banking of mature oocytes is to cryopreserve mature oocytes before they resume nuclear maturation and progress to metaphase II. At this stage of prophase I -the so-called germinal vesicle (GV) stage -the chromosomes are not aligned along the spindle, and there should, therefore, be a reduced risk of cytogenetic errors at subsequent divisions. However, cytoskeleton damage may still occur and the risk of zona hardening may be increased as the oocytes must undergo an extended period of culture to enable nuclear maturation to progress before fertilisation can occur in vitro. Using cryopreserved GV oocytes, high survival rates and birth rates have been achieved in mice 22 . However immature human oocytes have low post-thaw survival (37% 23 , and 43% 24 ) and in vitro maturation rates (20% 23 and 27% 24 ). Furthermore, very few pregnancies have been achieved after the in vitro maturation of fresh oocytes [25] [26] [27] and none after cryopreservation. At present, and until the efficiency of in vitro maturation improves, cryopreservation of GV oocytes offers little advantage over freeze-storage of metaphase II oocytes.
In contrast to cryopreservation of mature oocytes, freeze storage of embryos is routinely used in assisted reproductive technology and has occasionally proved successful before chemotherapy 28 . While this approach is relatively straight-forward, it hosts a number of inherent disadvantages for the conservation of fertility of cancer patients. IVF treatment and embryo storage is only suitable for patients of reproductive
Cryopreservation of gonadal tissue and cells age and treatment is both costly and lengthy -in many cases taking 4-6 weeks 29 . What is more, ovarian hyperstimulation, which is required if several oocytes are to be collected, may be contra-indicated in the case of steroid related cancers, and where there is no male partner, donor sperm is required. More importantly, this strategy is clearly not an option for prepubertal girls.
A radical, and perhaps more acceptable, approach which can be used by both young girls as well as adults is the cryopreservation of ovarian tissue. Ovarian tissue banking has the added potential of restoring normal ovarian function and natural fertility. Gonadal cryopreservation is of particular relevance to young women and girls who are diagnosed with cancer when they are too young to have either started or completed their families. In addition, high-dose chemotherapy is now being used for an increasing number of non-malignant conditions, such as autoimmune diseases and thalassaemias, for which tissue storage is also potentially attractive. Furthermore, fertility conservation by ovarian tissue cryopreservation may be a viable option for women with a familial history of premature ovarian failure as the methodology offers the potential to restore natural fertility by autografting the thawed tissue at either an orthotopic or heterotopic site.
The technique of ovarian cryopreservation involves freezing immature primordial follicles in situ in slices of ovarian cortex. In comparison with mature oocytes, primordial follicles are smaller and more tolerant to freezing and thawing as they lack a zona pellucida and cortical granules, are relatively metabolically quiescent and undifferentiated and have more time to repair sublethal damage to organelles and other structures during their prolonged growth phase. Above all, primordial follicles are the most abundant stage of follicular development present at every age, and hundreds of small follicles can be obtained using a simple biopsy procedure, or thousands if an oophorectomy is performed. Primordial follicles from humans [30] [31] [32] [33] and other species 34, 35 have successfully survived cryopreservation to liquid nitrogen temperatures. Paradoxically, while primordial follicles may be a more effective subject for tissue banking than mature oocytes, animal studies have demonstrated that it is precisely this stage of follicle development which is most susceptible to the effects of ionising radiation and alkylating agents 36, 37 . Cryopreservation and storage of testicular tissue slices may also be effective, and could provide an opportunity to preserve germ cells for prepubertal boys. Storage of spermatogonial stem cells or intact seminiferous tubules may provide the possibility of restoring spermatogenesis in vivo either by transferring stem cells back to the sterilised testes or by grafting tubules heterotopically for spermatogenesis in vivo and recovery of spermatozoa for an ICSI procedure 38, 39 . In the longer term, it may even be possible to produce enough spermatozoa for ICSI from cultured testicular tissue years after frozen banking testicular biopsies from children. In contrast to the successful cryopreservation of small pieces of gonadal tissue, at the present time, the freeze storage of whole gonads has only been achieved with the ovaries of small animals 40 or fetuses 41 and, therefore, remains only a remote possibility for use in humans.
Cryobiology of gonadal cells
When cells are cooled to temperatures between -5°C and -15°C, ice crystal formation is induced in the extracellular medium. As the temperature decreases further, the amount of ice increases, the solutes concentrate in the extracellular medium creating an osmotic gradient, and there is net water movement from the cytoplasm to the extracellular medium causing cellular shrinkage and dehydration. Cells undergoing cryopreservation are, therefore, liable to damage both from the formation of intracellular ice and from the build-up of salts in the cells as they dehydrate.
Protection from damage during freezing and thawing can be achieved through the use of a cryoprotective agent (CPA). The agents penetrate the cell membranes and are thought to stabilise intracellular proteins, reduce the temperature at which cells undergo lethal intracellular ice formation and moderate the impact of concentrated intra-and extracellular electrolytes 42 . Historically, glycerol, by virtue of its relative non-toxicity, has been extensively used as the CPA for sperm banking in animals and humans. However, its use for tissue preservation has been limited by its poor penetration qualities 30 . Consequently, in recent years, its use has been superseded by a number of new generation CPAs, namely, dimethylsulphoxide (DMSO), 1,2-propanediol (PROH) and ethylene glycol 43 . These cryoprotectants have high water-solubility, rapid penetrability and produce less osmotic damage at the high concentrations normally used in cryopreservation protocols; however, their effects on cellular viability are still largely unknown. For example, CPA exposure in mature oocytes has been implicated in alterations in the cytoskeleton 44 , microtubular structure, and spindle organisation 45 . Such effects may disrupt the normal organisation and traffic of molecules and organelles, impair embryonic development and increase the incidence of aneuploidy and other chromosomal anomalies. More recently, CPA exposure has been shown to promote the passive influx of Ca 2+ across the plasma membrane 46 , possibly by stimulating the release of Ca 2+ from storage sites in the mitochondria and endoplasmic reticulum. Such increases in intracellular Ca 2+ can lead to parthenogenetic activation of mature oocytes and are known to activate intracellular phospholipases, proteases, ATPases and endonucleases, resulting in altered plasma membrane integrity, denaturation of cystolic proteins, and chromosomal fragmentation -all of which can lead to irreversible cell injury and apoptosis.
In addition to the potential cytotoxic effects of CPA exposure, cryopreservation solutions are hyperosmotic and CPAs penetrate cells more slowly than water. Video microscopy of human oocytes has revealed that CPA exposure causes a 40% shrinkage of cellular volume as water is withdrawn down the osmotic gradient, followed by a return to normal volume as the CPA penetrates the cell 47 . When the oocyte is returned to the isotonic solution after thawing, there is an inward osmotic flux with the possibility of excessive swelling to 140-150% of the physiological volume (Fig. 1) . These volumetric changes may contribute to the mechanism for the induction of cytogenetic damage during cryopreservation of mature oocytes and, in extreme cases, can cause cellular lysis. Unlike cryopreservation of isolated cells, freeze-storage of tissue presents new problems because of the complexity of tissue architecture and protocols must strike a compromise between the optimal conditions for each different cell type. For example, the cooling and warming rates together with dehydration conditions which result in optimal survival of one cell type may not be ideal for other cellular components of the same piece of tissue. In addition, problems can arise when ice forms extracellularly, because it can cleave tissues into fragments. Furthermore, rapid solute penetration of highly compacted tissue is vital to ensure high final concentrations of cryoprotectant at temperatures which will minimise cytotoxicity 48 . These requirements necessitate optimisation of freeze/thaw protocols for each cell type, as post-thaw survival of reproductive cells and tissues are profoundly affected by both the type of cryoprotectant used 30 and the equilibration times required for cryoprotectant uptake and removal 48 . Despite the apparent difficulties compared with single cells, the storage of gonadal, and particularly ovarian, tissue has proved surprisingly successful. The suitability of ovarian tissue for freezing is enhanced by the developmental plasticity of the tissue as the ovary is capable of functioning even when its complement of follicles has been severely reduced such as naturally occurs during ageing, after partial ablation or after injury. Furthermore, the cortical distribution of primordial follicles permits the preparation of thin strips of tissue which provide maximal surface area for rapid CPA penetration, as evidenced by NMR spectroscopy 49 . Overall, the consensus of opinion suggests that, to minimise freeze-thaw injury, cooling rates should be fast enough to minimise exposure of cells to high intracellular concentrations of electrolyte and slow enough to avoid intracellular ice formation. Furthermore, these processes should be carried out in the presence of low concentrations of non-permeable osmolytes, such as sucrose and mannitol, to act as osmotic buffers against swelling during the addition and removal of CPAs 48 . In support of this recommendation, significantly more pregnancies have been achieved in mice after orthotopic ovarian transplantation when fast (86%), rather than slow (25%), thaw protocols were used 50 . Successful cryopreservation of human ovarian tissue with high post-thaw follicle survival rates of 84% and 74% have been achieved using the slow freeze, rapid rewarming protocol after immersion of £1 mm thick slices of ovarian cortex for 30 min at 4°C in freezing solution containing either 1.5M EG or DMSO with 0.1 M sucrose 30, 51 . The tissue can then be stored at liquid nitrogen temperatures (-196°C) for as long as required. Morphological assessments of cryopreserved human ovarian cortex at the light microscope level 30 , and examination of the fine structural integrity of tissue by electron microscopy 52 have confirmed that, in the hands of experienced cryobiologists, cellular damage in the tissue is minimal (Figs 2 & 3) . However, the choice of an inappropriate CPA together with poor laboratory practice may lead to increased cellular damage, and compromise tissue viability on thawing.
An alternative to the slow freezing protocols detailed above is rapid freezing. Here, increased concentrations of CPA dehydrate the cells before the ultra-rapid cooling rates allow the solutions to form glass (vitrify) rather than ice crystals (freeze) when they are plunged into liquid nitrogen 53 . Increasing both cryoprotectant concentration and the rate of cooling by using metal grids 54 and minimal volumes has enabled the successful vitrification of oocytes and embryos from a number of species 55, 56 . However, ultrarapid freezing regimens have proved less successful with human oocytes 57 and both the solute concentrations and cooling rates need to be optimised to prevent irreversible chromosome damage occurring.
Developmental potential of cryopreserved ovarian tissue
Although the histological evaluations detailed above indicate that human follicles can survive freezing, these morphological evaluations give no indication of the viability or long-term developmental potential of the stored tissue. Post-thaw, short-term maintenance of functional integrity of follicles from cryopreserved human ovarian cortex has been indicated by viability staining 31 , and follicular structure has been maintained in tissue culture 58 . Furthermore, encouraging results have been obtained using transplantation technology in experimental studies using both animals and humans. The in vivo developmental potential of primordial follicles from a number of species has been demonstrated by autografting or xenografting of both fresh and cryopreserved tissue under the kidney capsules of immunologically tolerant mice with severe combined immune deficiency 30, 34, 59 . For example, high rates of follicular survival have been obtained in the human xenograft model 30 and follicle survival was further improved by the use of exogenous antioxidants, such as vitamin E, to reduce ischaemia 60 . Furthermore, follicle growth was initiated up to early antral stages (10-12 layers of granulosa cells) by recombinant human FSH 59 . Experiments in sheep, whose ovaries more closely resemble the human ovary in size and follicle and fibre composition, have confirmed the practicability of restoring natural fertility by ovarian banking and autografting 51, 61, 62 . While autografts and, controversially, xenografts are already providing a practical basis for the restoration of natural fertility after ovarian tissue banking, the important proviso remains that the tissue does not harbour malignant cells that could reseed the old disease after grafting. Long-range hopes for the safe usage of cryopreserved gonadal tissues must, therefore, rest on the complete growth and development of follicles in vitro as a desirable method of generating oocytes and avoiding any risk of transmitting residual disease in autografts 63 . However, follicle culture technology is still in its infancy and the lack of detailed knowledge about the early stages of human follicle growth and survival is compounded by the large size of the Graafian follicle and a growth period of several months 64 . At present, our ability to preserve cells at low temperatures is ahead of methods to realise their fertile potential, and the techniques must, therefore, be regarded as experimental in both males and females. Furthermore, the human oocyte is clearly a difficult cell to cryopreserve being large with only a short fertile life-span and little capacity to repair damage unlike cleaving embryos which tolerate the loss of one or more blastomeres. Future advances in the technology to conserve fertility must, therefore, rely on an improved understanding of the cryobiology of gonadal cells, further optimisation of freezing protocols for each cell type, a new generation cell culture techniques and the development of new skills in reproductive surgery.
